US BANCORP \DE\ - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$14,404
-37.4%
898
-9.6%
0.00%
Q2 2023$23,018
+77.3%
993
+77.6%
0.00%
Q1 2023$12,986
+97.6%
559
+23.4%
0.00%
Q4 2022$6,573
-89.9%
453
-86.8%
0.00%
Q3 2022$65,000
-1.5%
3,422
-5.2%
0.00%
Q2 2022$66,000
-38.9%
3,608
-15.0%
0.00%
Q1 2022$108,000
+5.9%
4,243
+14.6%
0.00%
Q4 2021$102,000
-5.6%
3,702
+11.2%
0.00%
Q3 2021$108,000
+36.7%
3,328
+28.6%
0.00%
Q2 2021$79,000
+1480.0%
2,588
+426.0%
0.00%
Q2 2020$5,000
-70.6%
492
-60.1%
0.00%
Q1 2020$17,000
+112.5%
1,234
+343.9%
0.00%
Q4 2019$8,000
-11.1%
278
-9.2%
0.00%
Q3 2019$9,000
+50.0%
306
+39.1%
0.00%
Q2 2019$6,000
-73.9%
220
-68.9%
0.00%
Q1 2019$23,000
-61.0%
707
-65.1%
0.00%
Q4 2018$59,000
+43.9%
2,025
+126.0%
0.00%
Q3 2018$41,000
+28.1%
896
+4.8%
0.00%
Q2 2018$32,000
+23.1%
8550.0%0.00%
Q1 2018$26,000
-67.5%
855
-63.2%
0.00%
Q4 2017$80,000
-2.4%
2,326
+1.7%
0.00%
Q3 2017$82,000
+78.3%
2,287
+28.0%
0.00%
Q2 2017$46,000
+12.2%
1,787
-14.8%
0.00%
Q1 2017$41,000
+17.1%
2,097
+2.3%
0.00%
Q4 2016$35,000
+150.0%
2,050
+192.4%
0.00%
Q3 2016$14,000
-88.9%
701
-83.0%
0.00%
Q2 2016$126,000
+26.0%
4,122
+55.0%
0.00%
Q1 2016$100,000
-37.9%
2,660
-28.8%
0.00%
-100.0%
Q4 2015$161,000
-11.5%
3,738
-22.9%
0.00%0.0%
Q3 2015$182,000
-7.6%
4,851
-16.3%
0.00%0.0%
Q2 2015$197,000
-65.1%
5,798
-63.6%
0.00%
-50.0%
Q1 2015$565,000
+12.5%
15,944
+8.1%
0.00%0.0%
Q4 2014$502,000
-9.5%
14,748
+2.4%
0.00%0.0%
Q3 2014$555,000
+2.4%
14,398
+3.4%
0.00%0.0%
Q2 2014$542,000
+6.1%
13,928
-6.9%
0.00%0.0%
Q1 2014$511,000
+18.0%
14,953
-27.6%
0.00%0.0%
Q4 2013$433,000
-45.2%
20,642
-38.6%
0.00%
-33.3%
Q3 2013$790,000
-5.3%
33,606
+8.2%
0.00%
-25.0%
Q2 2013$834,00031,0550.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders